ClearOne Reports Third Quarter 2019 Financial Results
- Q3 Microphone revenue up year-over-year by 3%
- Q3 Overall revenue down year-over-year by 10% — continued to be impacted by infringement of ClearOne’s strategic patents
- Non-GAAP Operating expenses declined by 14% year-over-year
“We have seen modest improvements in our microphone sales after the recent decision by a
“We will continue our focus on technological innovation, cost management and vigorous enforcement of our intellectual property rights.”
The preliminary injunction relating to ClearOne’s U.S. Patent No. 9,813,806 (the “Graham Patent”) became effective on
A preliminary injunction is an extraordinary remedy that is rarely granted. In granting ClearOne’s request, the Court acknowledged the strength of ClearOne’s position against
Financial Summary
The Company uses certain non-GAAP financial measures and reconciles those to GAAP measures in the attached tables.
- Q3 2019 revenue was
$6.0 million , compared to$6.7 million in Q3 2018 and$6.4 million in Q2 2019. The year-over-year and sequential decrease reflects an impact of the on-going harm of infringement of ClearOne’s patents on its audio conferencing products and microphones. The patent infringement also has negatively impacted directly the revenue from ClearOne’s other products. - GAAP gross profit in Q3 2019 was
$2.5 million compared to$3.0 million in Q3 2018 and$2.9 million in Q2 2019. GAAP gross profit margin was 42% in Q3 2019, compared to 45% in Q3 2018 and 46% in Q2 2019. Gross Profit margin decreased year over year mainly due to an increase in inventory obsolescence costs. - Operating expenses in Q3 2019 were
$4.6 million , compared to$5.3 million in Q3 2018 and$5.0 million in Q2 2019. Non-GAAP operating expenses in Q3 2019 were$4.2 million , compared to$4.9 million in Q3 2018 and$4.7 million in Q2 2019. The majority of the decrease in Q3 2019 operating expenses over Q3 2018 is attributable to decreases in employee-related costs including benefits and commissions and allocations of overhead expenses, partially offset by an increase in demonstration inventory costs. - GAAP net loss in Q3 2019 was
$2.0 million , or$0.12 per share, compared to net loss of$10.1 million , or$1.22 per share, in Q3 2018 and net loss of$2.1 million , or$0.13 per share, in Q2 2019. Net loss in Q3 2019 was largely caused by operating losses on account of the reduction in revenue and associated gross profit. Net loss in Q3 2019 was lower than net loss in Q3 2018 largely due to reduced tax expense and reduced operating expenses offset by reduced gross profit. During 2018-Q3, the Company recorded discrete tax expense of$6.5 million , due primarily to the recording of a full valuation allowance on the Company's net deferred tax assets. Non-GAAP net loss was$1.6 million , or$0.09 per share, in Q3 2019, compared to non-GAAP net loss of$9.6 million , or$1.15 per share in Q3 2018 and non-GAAP net loss of$1.7 million , or$0.10 per share, in Q2 2019.
Financial Summary
($ in 000, except per share) | Three months ended September 30, | Nine months ended September 30, | |||||||||||||||||||||
2019 | 2018 | Change | 2019 | 2018 | Change | ||||||||||||||||||
GAAP | |||||||||||||||||||||||
Revenue | $ | 5,992 | $ | 6,683 | -10 | % | $ | 18,717 | $ | 20,943 | -11 | % | |||||||||||
Gross Profit | 2,537 | 2,980 | -15 | % | 8,180 | 10,329 | -21 | % | |||||||||||||||
Operating loss | (2,098 | ) | (2,310 | ) | 9 | % | (6,593 | ) | (7,724 | ) | 15 | % | |||||||||||
Net loss | (1,976 | ) | (10,142 | ) | 81 | % | (6,423 | ) | (14,151 | ) | 55 | % | |||||||||||
Diluted loss per share | (0.12 | ) | (1.22 | ) | 90 | % | (0.39 | ) | (1.70 | ) | 77 | % | |||||||||||
Non-GAAP | |||||||||||||||||||||||
Non-GAAP gross profit | $ | 2,539 | $ | 2,983 | -15 | % | $ | 8,186 | $ | 10,341 | -21 | % | |||||||||||
Non-GAAP operating loss | (1,695 | ) | (1,915 | ) | 11 | % | (5,361 | ) | (6,430 | ) | 17 | % | |||||||||||
Non-GAAP net loss | (1,573 | ) | (9,554 | ) | 84 | % | (5,191 | ) | (12,857 | ) | 60 | % | |||||||||||
Non-GAAP Adjusted EBITDA | (1,436 | ) | (1,790 | ) | 20 | % | (4,751 | ) | (5,975 | ) | 20 | % | |||||||||||
Non-GAAP loss per share (diluted) | (0.09 | ) | (1.15 | ) | 92 | % | (0.31 | ) | (1.55 | ) | 80 | % |
Balance Sheet Highlights
At
About
Non-GAAP Financial Measures
To supplement our consolidated financial statements presented on a GAAP basis,
Forward Looking Statements
This release contains “forward-looking” statements that are based on present circumstances and on ClearOne’s predictions with respect to events that have not occurred, that may not occur, or that may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking statements and any statements of the plans and objectives of management for future operations and forecasts of future growth and value, are not guarantees of future performance or results and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements. Such forward-looking statements are made only as of the date of this release and
Contact:
Investor Relations
801-975-7200
investor_relations@clearone.com
http://investors.clearone.com
CONSOLIDATED BALANCE SHEETS
(Dollars in thousands, except par value)
September 30, 2019 |
December 31, 2018 |
||||||
ASSETS | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 2,010 | $ | 11,211 | |||
Marketable securities | 1,640 | 951 | |||||
Receivables, net of allowance for doubtful accounts of $709 and $631, respectively | 6,319 | 6,782 | |||||
Inventories, net | 11,689 | 13,228 | |||||
Prepaid expenses and other assets | 5,638 | 2,193 | |||||
Total current assets | 27,296 | 34,365 | |||||
Long-term marketable securities | 2,243 | 3,764 | |||||
Long-term inventories, net | 7,143 | 8,953 | |||||
Property and equipment, net | 1,099 | 1,388 | |||||
Operating lease - right of use assets, net | 2,547 | — | |||||
Intangibles, net | 12,609 | 10,249 | |||||
Other assets | 197 | 196 | |||||
Total assets | $ | 53,134 | $ | 58,915 | |||
LIABILITIES AND SHAREHOLDERS' EQUITY | |||||||
Current liabilities: | |||||||
Accounts payable | $ | 1,735 | $ | 3,729 | |||
Accrued liabilities | 2,864 | 1,996 | |||||
Deferred product revenue | 227 | 283 | |||||
Total current liabilities | 4,826 | 6,008 | |||||
Deferred rent | — | 135 | |||||
Operating lease liability | 2,129 | — | |||||
Other long-term liabilities | 195 | 571 | |||||
Total liabilities | 7,150 | 6,714 | |||||
Shareholders' equity: | |||||||
Common stock, par value $0.001, 50,000,000 shares authorized, 16,646,323 and 16,630,597 shares issued and outstanding | 17 | 17 | |||||
Additional paid-in capital | 58,037 | 57,840 | |||||
Accumulated other comprehensive loss | (172 | ) | (181 | ) | |||
Accumulated deficit | (11,898 | ) | (5,475 | ) | |||
Total shareholders' equity | 45,984 | 52,201 | |||||
Total liabilities and shareholders' equity | $ | 53,134 | $ | 58,915 |
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(Dollars in thousands, except per share values)
Three months ended September 30, |
Nine months ended September 30, |
||||||||||||||
2019 | 2018 | 2019 | 2018 | ||||||||||||
Revenue | $ | 5,992 | $ | 6,683 | $ | 18,717 | $ | 20,943 | |||||||
Cost of goods sold | 3,455 | 3,703 | 10,537 | 10,614 | |||||||||||
Gross profit | 2,537 | 2,980 | 8,180 | 10,329 | |||||||||||
Operating expenses: | |||||||||||||||
Sales and marketing | 1,907 | 2,168 | 6,121 | 7,796 | |||||||||||
Research and product development | 1,428 | 1,781 | 4,322 | 5,757 | |||||||||||
General and administrative | 1,300 | 1,341 | 4,330 | 4,500 | |||||||||||
Total operating expenses | 4,635 | 5,290 | 14,773 | 18,053 | |||||||||||
Operating loss | (2,098 | ) | (2,310 | ) | (6,593 | ) | (7,724 | ) | |||||||
Other income, net | 142 | 5 | 235 | 78 | |||||||||||
Loss before income taxes | (1,956 | ) | (2,305 | ) | (6,358 | ) | (7,646 | ) | |||||||
Provision for (benefit from) income taxes | 20 | 7,837 | 65 | 6,505 | |||||||||||
Net loss | $ | (1,976 | ) | $ | (10,142 | ) | $ | (6,423 | ) | $ | (14,151 | ) | |||
Basic weighted average shares outstanding | 16,646,323 | 8,306,707 | 16,635,954 | 8,304,974 | |||||||||||
Diluted weighted average shares outstanding | 16,646,323 | 8,306,707 | 16,635,954 | 8,304,974 | |||||||||||
Basic loss per share | $ | (0.12 | ) | $ | (1.22 | ) | $ | (0.39 | ) | $ | (1.70 | ) | |||
Diluted loss per share | $ | (0.12 | ) | $ | (1.22 | ) | $ | (0.39 | ) | $ | (1.70 | ) | |||
Comprehensive loss: | |||||||||||||||
Net loss | $ | (1,976 | ) | $ | (10,142 | ) | $ | (6,423 | ) | $ | (14,151 | ) | |||
Unrealized gain (loss) on available-for-sale securities, net of tax | (78 | ) | (22 | ) | 76 | (93 | ) | ||||||||
Change in foreign currency translation adjustment | (50 | ) | (13 | ) | (67 | ) | (51 | ) | |||||||
Comprehensive loss | $ | (2,104 | ) | $ | (10,177 | ) | $ | (6,414 | ) | $ | (14,295 | ) |
UNAUDITED RECONCILIATION OF GAAP MEASURES TO NON-GAAP MEASURES
(Dollars in thousands, except per share values)
Three months ended September 30, |
Nine months ended September 30, |
||||||||||||||
2019 | 2018 | 2019 | 2018 | ||||||||||||
GAAP gross profit | $ | 2,537 | $ | 2,980 | $ | 8,180 | $ | 10,329 | |||||||
Stock-based compensation | 2 | 3 | 6 | 12 | |||||||||||
Non-GAAP gross profit | $ | 2,539 | $ | 2,983 | $ | 8,186 | $ | 10,341 | |||||||
GAAP operating loss | $ | (2,098 | ) | $ | (2,310 | ) | $ | (6,593 | ) | $ | (7,724 | ) | |||
Stock-based compensation | 48 | 112 | 177 | 379 | |||||||||||
Amortization of intangibles | 355 | 279 | 1,055 | 792 | |||||||||||
Legal expenses not related to regular operations | — | 4 | — | 123 | |||||||||||
Non-GAAP operating loss | $ | (1,695 | ) | $ | (1,915 | ) | $ | (5,361 | ) | $ | (6,430 | ) | |||
GAAP net loss | $ | (1,976 | ) | $ | (10,142 | ) | $ | (6,423 | ) | $ | (14,151 | ) | |||
Stock-based compensation | 48 | 112 | 177 | 379 | |||||||||||
Amortization of intangibles | 355 | 279 | 1,055 | 792 | |||||||||||
Legal expenses not related to regular operations | — | 4 | — | 123 | |||||||||||
Tax effect of non-GAAP adjustments | — | 193 | — | — | |||||||||||
Non-GAAP net loss | $ | (1,573 | ) | $ | (9,554 | ) | $ | (5,191 | ) | $ | (12,857 | ) | |||
GAAP net loss | $ | (1,976 | ) | $ | (10,142 | ) | $ | (6,423 | ) | $ | (14,151 | ) | |||
Number of shares used in computing GAAP loss per share (diluted) | 16,646,323 | 8,306,707 | 16,635,954 | 8,304,974 | |||||||||||
GAAP loss per share (diluted) | $ | (0.12 | ) | $ | (1.22 | ) | $ | (0.39 | ) | $ | (1.70 | ) | |||
Non-GAAP net loss | $ | (1,573 | ) | $ | (9,554 | ) | $ | (5,191 | ) | $ | (12,857 | ) | |||
Number of shares used in computing Non-GAAP loss per share (diluted) | 16,646,323 | 8,306,707 | 16,635,954 | 8,304,974 | |||||||||||
Non-GAAP loss per share (diluted) | $ | (0.09 | ) | $ | (1.15 | ) | $ | (0.31 | ) | $ | (1.55 | ) | |||
GAAP net loss | $ | (1,976 | ) | $ | (10,142 | ) | $ | (6,423 | ) | $ | (14,151 | ) | |||
Stock-based compensation | 48 | 112 | 177 | 379 | |||||||||||
Depreciation | 117 | 120 | 375 | 377 | |||||||||||
Amortization of intangibles | 355 | 279 | 1,055 | 792 | |||||||||||
Legal expenses not related to regular operations | — | 4 | — | 123 | |||||||||||
Provision for (benefit from) income taxes | 20 | 7,837 | 65 | 6,505 | |||||||||||
Non-GAAP Adjusted EBITDA | $ | (1,436 | ) | $ | (1,790 | ) | $ | (4,751 | ) | $ | (5,975 | ) |
Source: ClearOne, Inc.